Ameela, launched by Amedica Group in June 2023 (formerly known as Nucleadyn), is a next-generation injectable polynucleotide treatment. As the first and longest-running distributor of injectable polynucleotides, Amedica Group leads the way in regenerative medicine.

Extracted from salmon DNA and purified at high temperatures, Ameela ensures over 95% pure active substance, free from proteins and hormones, minimising immunological risks and guaranteeing product safety. This innovative therapy restores skin firmness and elasticity while protecting against free radicals and cellular damage.

How Ameela Works ?
Once injected, Ameela activates multiple cell receptors, triggering a series of regenerative responses:

• Stem Cell Attraction: Repairs damaged tissue and enhances healing.

• Angiogenesis: Promotes the formation of new capillaries, improving skin vitality.

• Collagen Stimulation: Tightens and contours the skin by transforming fibroblasts into myofibroblasts, creating an instant lifting and revitalising effect.

Ameela is a safe and effective solution for all skin types, offering strong lifting, firming, and skin rejuvenation benefits.